Moderate Renal Impairment research hub

Phase Ib Randomised, Placebo-controlled, Double-blind, Multicentre Study to Assess the Effects and Safety of AZD5462 on top of Dapagliflozin in Participants with Heart Failure and Moderate Renal Impairment

This study is looking at a new medicine called AZD5462, given with another medicine (Dapagliflozin), for people with heart failure and kidney problems. It checks if the new medicine is safe and how well it works.